Stockreport

Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF SAN MATEO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics [Read more]